CORAL GABLES, Fla., Oct. 9, 2023 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq:RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announced that Sergio Traversa, Chief Executive Officer, Maged Shenouda, Chief Financial Officer, and Cedric O'Gorman, Chief Medical Officer, will participate in the Jefferies Inaugural Biotech CNS/Neuro Summit in one-on-one investor meetings and a fireside chat on Thursday, October 12, 2023, at 2:30pm ET in New York, NY. Please find additional details about the event below.
Read more at prnewswire.comRelmada Therapeutics to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit
PR Newswire -
Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/Microsoft%20Corporation%20logo%20on%20phone-by%20rafapress%20via%20Shuterstock.jpg)